glucose, (beta-d)-isomer has been researched along with Cognitive Dysfunction in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (30.00) | 24.3611 |
| 2020's | 21 (70.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirose, M; Ishida, N; Saito, M; Sanbe, A; Sato, S; Taira, E; Tezuka, Y | 1 |
| Abdelsalam, RM; El-Safty, H; El-Sahar, AE; Ismail, A; Saad, MA | 1 |
| He, JC; He, ZQ; Huan, PF; Wang, L | 1 |
| Frullone, S; Gambardella, J; Lombardi, A; Macina, G; Mone, P; Morgante, M; Pansini, A; Santulli, G | 2 |
| He, J; He, XL; Li, M; Lian, WW; Liu, LQ; Pan, CH; Wang, YM; Wang, ZX; Xu, JK; Zhang, WK | 1 |
| Duan, F; Ju, T; Lu, W; Qin, Y; Shan, S; Shi, Y; Song, C; Zeng, D; Zhang, Y | 1 |
| Dai, GL; Meng, QH; Pan, CL; Tan, QL; Wang, XL; Xu, L; Xu, N; Zhang, CY; Zhang, HW; Zhang, Y; Zhang, ZY | 1 |
| Gu, N; Liang, B | 1 |
| Chen, T; Chen, Y; Li, Y; Shen, X; Tao, L; Xu, Y; Yang, H; Zhang, E | 1 |
| Cho, EJ; Kim, HY; Kim, JH; Lee, AY; Meng, HW | 1 |
| Chen, TT; Chen, Y; Chen, YX; Shen, XC; Tao, L; Wang, DS; Yang, H; Yao, YT | 1 |
| He, W; Huang, Y; Li, M; Li, W; Luo, Y; Mei, Y; Pan, H; Wan, T; Wang, Q; Wang, Z; Xue, J; Zhang, Y | 1 |
| Chen, S; Li, Q; Sun, S; Wang, H | 1 |
| Alves-Martinez, P; Carranza-Naval, MJ; Del Marco, A; Garcia-Alloza, M; Herrera, M; Hierro-Bujalance, C; Infante-Garcia, C; Lubian-Lopez, S; Suarez, J | 1 |
| Gao, Y; Hu, C; Li, J; Li, L; Yan, J; Zhang, L | 1 |
| Cui, G; Deng, CK; Huang, YJ; Lei, B; Miao, YH; Mu, ZH; Qian, ZY; Shen, X; Song, JL; Wang, YY; Wu, XY; Zhang, F; Zhang, WQ; Zhang, Y; Zhou, RD; Zou, YY | 1 |
| Aigbirhio, FI; Bevan-Jones, WR; Carter, SF; Fryer, TD; Hong, YT; Mak, E; Malpetti, M; Nicastro, N; O'Brien, JT; Passamonti, L; Rowe, JB; Williams, GB | 1 |
| Li, R; Li, X; Tian, SY; Wang, CY; Xin, N; Xu, Y; Xun, Z; Yuan, L; Zhang, Q | 1 |
| Chen, J; Gao, L; Kong, Z; Su, Y; Wang, D; Yan, M; Zhang, Y | 1 |
| Chen, C; Gao, D; Huang, R; Li, L; Miao, BB; Yang, CC; Zhang, L | 1 |
| Akhtar, M; Ali, J; Khan, S; Khan, T; Najmi, AK | 1 |
| Chin, YW; Cho, J; Moniruzzaman, M | 1 |
| Li, S; Liu, L; Wang, C; Wang, D | 1 |
| Dong, H; Hao, X; Yuan, J | 1 |
| He, S; Meng, X; Sun, G; Sun, X; Wang, R; Ye, T; Zhang, C | 1 |
| Lu, X; Xiao-Qing, C | 1 |
| Shen, QQ; Shi, CG; Wang, HF; Wang, LJ; Zhang, LG; Zhang, MY; Zhang, SC; Zhang, Y | 1 |
| Chen, W; Deng, W; Guo, J; Han, Y; Qin, C; Song, N; Zhang, L; Zhu, H | 1 |
| Dong, M; Jiang, A; Liang, L; Ma, J; Ma, Z; Sun, X | 1 |
30 other study(ies) available for glucose, (beta-d)-isomer and Cognitive Dysfunction
| Article | Year |
|---|---|
Mizagliflozin, a selective SGLT1 inhibitor, improves vascular cognitive impairment in a mouse model of small vessel disease.
Topics: Animals; Carotid Artery, Common; Cerebral Small Vessel Diseases; Cerebrovascular Circulation; Cognition; Cognitive Dysfunction; Cytokines; Disease Models, Animal; Glucosides; Hippocampus; Inflammation; Mice; Morris Water Maze Test; Neurons; Phlorhizin; Pyrazoles; Sodium-Glucose Transporter 1 | 2021 |
Dapagliflozin diminishes memory and cognition impairment in Streptozotocin induced diabetes through its effect on Wnt/β-Catenin and CREB pathway.
Topics: Animals; Behavior, Animal; Benzhydryl Compounds; Cognitive Dysfunction; Cyclic AMP Response Element-Binding Protein; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Glucosides; Glycogen Synthase Kinase 3 beta; Memory Disorders; Neuroprotective Agents; Rats; Signal Transduction; Wnt3 Protein | 2022 |
Paeoniflorin ameliorates cognitive impairment in Parkinson's disease via JNK/p53 signaling.
Topics: Animals; Cognitive Dysfunction; Dopaminergic Neurons; Glucosides; Mice; Molecular Docking Simulation; Monoterpenes; Parkinson Disease; Signal Transduction; Tumor Suppressor Protein p53 | 2022 |
Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction.
Topics: Aged; Benzhydryl Compounds; Cognitive Dysfunction; Diabetes Mellitus, Type 2; Frail Elderly; Glucosides; Heart Failure; Humans; Insulins; Metformin; Prospective Studies; Stroke Volume | 2022 |
Cornuside ameliorates cognitive impairments in scopolamine induced AD mice: Involvement of neurotransmitter and oxidative stress.
Topics: Acetylcholine; Acetylcholinesterase; Alzheimer Disease; Amnesia; Animals; Butyrylcholinesterase; Choline O-Acetyltransferase; Cognitive Dysfunction; Glucosides; Hippocampus; Maze Learning; Mice; Mice, Inbred ICR; Monoamine Oxidase; Neurotransmitter Agents; Oxidative Stress; Pyrans; Scopolamine; Superoxide Dismutase | 2022 |
Eleutheroside E supplementation prevents radiation-induced cognitive impairment and activates PKA signaling via gut microbiota.
Topics: Animals; Cognitive Dysfunction; Dietary Supplements; Gastrointestinal Microbiome; Glucosides; Lignans; Mice | 2022 |
Salidroside ameliorates orthopedic surgery-induced cognitive dysfunction by activating adenosine 5'-monophosphate-activated protein kinase signaling in mice.
Topics: Adenosine; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Cognitive Dysfunction; Glucosides; Mice; Mice, Inbred C57BL; Microglia; Molecular Docking Simulation; Orthopedic Procedures; Phenols | 2022 |
Response to Comment on Mone et al. Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction. Diabetes Care 2022;45:1247-1251.
Topics: Aged; Benzhydryl Compounds; Cognitive Dysfunction; Diabetes Mellitus, Type 2; Frail Elderly; Glucosides; Heart Failure; Humans; Stroke Volume | 2022 |
Comment on Mone et al. Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction. Diabetes Care 2022;45:1247-1251.
Topics: Aged; Benzhydryl Compounds; Cognitive Dysfunction; Diabetes Mellitus, Type 2; Frail Elderly; Glucosides; Heart Failure; Humans; Stroke Volume | 2022 |
Gastrodin Ameliorates Cognitive Dysfunction in Vascular Dementia Rats by Suppressing Ferroptosis via the Regulation of the Nrf2/Keap1-GPx4 Signaling Pathway.
Topics: Animals; Benzyl Alcohols; Cognitive Dysfunction; Cyclooxygenase 2; Dementia, Vascular; Ferroptosis; Glucosides; Glutathione; Kelch-Like ECH-Associated Protein 1; Malondialdehyde; NF-E2-Related Factor 2; Oleanolic Acid; Phospholipid Hydroperoxide Glutathione Peroxidase; Rats; Signal Transduction | 2022 |
Paeoniflorin Attenuates Lipopolysaccharide-Induced Cognitive Dysfunction by Inhibition of Amyloidogenesis in Mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Cognitive Dysfunction; Disease Models, Animal; Glucosides; Lipopolysaccharides; Maze Learning; Memory Disorders; Mice; Mice, Transgenic; Monoterpenes | 2023 |
Gastrodin relieves cognitive impairment by regulating autophagy via PI3K/AKT signaling pathway in vascular dementia.
Topics: Animals; Autophagy; Cognitive Dysfunction; Dementia, Vascular; Glucosides; Hypoxia; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction | 2023 |
FA-97, a New Synthetic Caffeic Acid Phenethyl Ester Derivative, Protects against Oxidative Stress-Mediated Neuronal Cell Apoptosis and Scopolamine-Induced Cognitive Impairment by Activating Nrf2/HO-1 Signaling.
Topics: Alzheimer Disease; Animals; Apoptosis; Caffeic Acids; Cognitive Dysfunction; Disease Models, Animal; Glucosides; Heme Oxygenase-1; Humans; Male; Mice; Mice, Inbred Strains; Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; PC12 Cells; Phenylethyl Alcohol; Rats; RNA, Small Interfering; Scopolamine; Signal Transduction | 2019 |
Neuroprotective Effects of Salidroside in a Mouse Model of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cognitive Dysfunction; Disease Models, Animal; Glucosides; Mice, Inbred C57BL; Mice, Transgenic; Neuroprotective Agents; Phenols; Phosphatidylinositol 3-Kinases; Signal Transduction; TOR Serine-Threonine Kinases | 2020 |
Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer's disease and type 2 diabetes.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Benzhydryl Compounds; Brain; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Female; Glucosides; Male; Mice; Mice, Transgenic | 2020 |
Tetrahydroxy stilbene glycoside alleviated inflammatory damage by mitophagy via AMPK related PINK1/Parkin signaling pathway.
Topics: Alzheimer Disease; AMP-Activated Protein Kinases; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Anti-Inflammatory Agents; Cell Line, Tumor; Cognitive Dysfunction; Disease Models, Animal; Gene Expression Regulation; Glucosides; Humans; Inflammasomes; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Mitochondria; Mitophagy; Neurons; Neuroprotective Agents; NLR Family, Pyrin Domain-Containing 3 Protein; Primary Cell Culture; Protein Kinases; RNA, Small Interfering; Signal Transduction; Stilbenes; Ubiquitin-Protein Ligases | 2020 |
Early Intervention of Gastrodin Improved Motor Learning in Diabetic Rats Through Ameliorating Vascular Dysfunction.
Topics: Animals; Apoptosis; Behavior, Animal; Benzyl Alcohols; Cerebellar Cortex; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Endothelium, Vascular; Glucosides; Locomotion; Male; Nitric Oxide; Nitric Oxide Synthase; Purkinje Cells; Rats, Sprague-Dawley; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2020 |
Gray matter changes related to microglial activation in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cerebral Cortex; Cognitive Dysfunction; Diffusion Tensor Imaging; Female; Glucosides; Gray Matter; Humans; Immunotherapy; Inflammation; Male; Microglia; Steroids | 2020 |
Increases of iASPP-Keap1 interaction mediated by syringin enhance synaptic plasticity and rescue cognitive impairments via stabilizing Nrf2 in Alzheimer's models.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Cognitive Dysfunction; Glucosides; Kelch-Like ECH-Associated Protein 1; Mice; Mice, Transgenic; Neuronal Plasticity; NF-E2-Related Factor 2; Oxidative Stress; Phenylpropionates; Tumor Suppressor Protein p53 | 2020 |
Acteoside-improved streptozotocin-induced learning and memory impairment by upregulating hippocampal insulin, glucose transport, and energy metabolism.
Topics: Alzheimer Disease; Animals; Brain; Cognition; Cognitive Dysfunction; Energy Metabolism; Glucose; Glucosides; Hippocampus; Insulin; Male; Maze Learning; Memory Disorders; Phenols; Rats; Rats, Sprague-Dawley; Receptor, Insulin; Streptozocin | 2021 |
Tetrahydroxy Stilbene Glucoside Ameliorates Cognitive Impairments and Pathology in APP/PS1 Transgenic Mice.
Topics: Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Cognitive Dysfunction; Glucosides; Hippocampus; Memory Disorders; Mice, Transgenic; Peptide Fragments; Presenilin-1; Stilbenes | 2021 |
Empagliflozin nanoparticles attenuates type2 diabetes induced cognitive impairment via oxidative stress and inflammatory pathway in high fructose diet induced hyperglycemic mice.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Cognitive Dysfunction; Diabetes Mellitus, Type 2; Fructose; Glucosides; Hyperglycemia; Inflammation Mediators; Mice; Mice, Inbred C57BL; Nanoparticles; Oxidative Stress; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
HO-1 dependent antioxidant effects of ethyl acetate fraction from Physalis alkekengi fruit ameliorates scopolamine-induced cognitive impairments.
Topics: Acetates; Animals; Antioxidants; Cell Line; Cognitive Dysfunction; Fruit; Glucosides; Heme Oxygenase-1; Luteolin; Male; MAP Kinase Signaling System; Memory Disorders; Mice, Inbred ICR; Physalis; Proto-Oncogene Proteins c-akt; Scopolamine | 2018 |
Effects of paeoniflorin on neurobehavior, oxidative stress, brain insulin signaling, and synaptic alterations in intracerebroventricular streptozotocin-induced cognitive impairment in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibiotics, Antineoplastic; Brain; Cognitive Dysfunction; Disease Models, Animal; Electron Transport Complex IV; Glucosides; Injections, Intraventricular; Insulin; Male; Maze Learning; Membrane Potentials; Mice; Mice, Inbred C57BL; Mitochondria; Monoterpenes; Oxidative Stress; Recognition, Psychology; Signal Transduction; Streptozocin; Synapses | 2018 |
Salidroside prevents diabetes‑induced cognitive impairment via regulating the Rho pathway.
Topics: Animals; Apoptosis; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Gene Expression Regulation; Glucosides; Male; Oxidative Stress; Phenols; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Signal Transduction | 2019 |
Gastrodin Alleviates Cognitive Dysfunction and Depressive-Like Behaviors by Inhibiting ER Stress and NLRP3 Inflammasome Activation in db/db Mice.
Topics: Animals; Apoptosis; Behavior, Animal; Benzyl Alcohols; Blood Glucose; Body Weight; Cognitive Dysfunction; Depression; Dyslipidemias; Endoplasmic Reticulum Stress; Glucosides; Inflammasomes; Insulin Resistance; Male; Memory; Mice; Models, Biological; Neurons; Neuroprotective Agents; NLR Family, Pyrin Domain-Containing 3 Protein | 2018 |
Eleutheroside E attenuates isoflurane-induced cognitive dysfunction by regulating the α7-nAChR-NMDAR pathway.
Topics: Acetylcholine; Animals; Cognition; Cognitive Dysfunction; Glucosides; Hippocampus; Isoflurane; Lignans; Male; Memory; Neuroprotective Agents; Nicotinic Agonists; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Receptors, Nicotinic | 2019 |
Paeoniflorin improves regional cerebral blood flow and suppresses inflammatory factors in the hippocampus of rats with vascular dementia.
Topics: Animals; Cerebrovascular Circulation; Cognitive Dysfunction; Cyclooxygenase 2; Dementia, Vascular; Down-Regulation; Glucosides; Hippocampus; Inflammation Mediators; Male; Maze Learning; Memory Disorders; Monoterpenes; Nitric Oxide Synthase Type II; Rats, Sprague-Dawley; RNA, Messenger; Transcription Factor RelA | 2017 |
Cyanidin 3-O-β-glucopyranoside activates peroxisome proliferator-activated receptor-γ and alleviates cognitive impairment in the APP(swe)/PS1(ΔE9) mouse model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Anthocyanins; Apoptosis; Brain; Cell Line; Cognitive Dysfunction; Disease Models, Animal; Female; Glucose; Glucosides; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mice, Transgenic; Microscopy, Electron, Transmission; Neurons; Peptide Fragments; PPAR gamma; Presenilin-1; Protein Aggregation, Pathological; Reactive Oxygen Species; Recombinant Fusion Proteins | 2016 |
Protective effects of salidroside against isoflurane-induced cognitive impairment in rats.
Topics: Acetylcholine; Acetylcholinesterase; Anesthetics, Inhalation; Animals; Antioxidants; Choline O-Acetyltransferase; Cognitive Dysfunction; Cytokines; Dose-Response Relationship, Drug; Gene Expression Regulation; Glucosides; Hippocampus; Isoflurane; Male; Phenols; Random Allocation; Rats; Rats, Sprague-Dawley | 2017 |